Lorraine, Canada

Anne E G Lenferink

USPTO Granted Patents = 6 


Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Anne E G Lenferink: Pioneering Innovator in the Realm of Inventions

Introduction:

Meet Anne E G Lenferink, a visionary inventor based in Lorraine, CA, whose dedication to innovation and relentless pursuit of excellence have solidified her reputation as a trailblazer in the world of inventions. Lenferink's passion for creating solutions that make a difference sets her apart as a forward-thinking inventor with a promising future ahead.

Latest Patents:

1. TGF-β-receptor ectodomain fusion molecules and uses thereof

2. Carbonic anhydrase IX-specific antibodies and uses thereof

Career Highlights:

With a total of 5 patents to her name, Lenferink's latest inventions focus on groundbreaking solutions for treating disorders related to TGF-beta expression, such as cancer and fibrotic diseases. Her work showcases a deep understanding of molecular biology and a commitment to developing therapeutic tools that can make a tangible impact on patients' lives.

Collaborations:

Lenferink is associated with the National Research Council of Canada, a renowned institution known for fostering cutting-edge research and innovation. Alongside coworkers Maureen D O'Connor-McCourt and Christiane Cantin, Lenferink collaborates with top experts in the field to push the boundaries of scientific discovery and bring novel inventions to fruition.

Conclusion:

In conclusion, Anne E G Lenferink's innovative spirit and groundbreaking patents underscore her position as a visionary inventor shaping the future of healthcare and biotechnology. Her remarkable contributions to the field of inventions pave the way for transformative advancements in treating complex diseases, reflecting her unwavering commitment to driving positive change through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…